A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Belimumab in Subjects With Generalized Myasthenia Gravis (MG)
Phase of Trial: Phase II
Latest Information Update: 11 Feb 2017
At a glance
- Drugs Belimumab (Primary)
- Indications Myasthenia gravis
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 22 Jan 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 13 Aug 2015 According to the ClinicalTrials.gov record, planned end date changed from 1 Oct 2015 to 1 Nov 2015.
- 13 Aug 2015 According to the ClinicalTrials.gov record, planned primary completion date changed from 1 Jul 2015 to 1 Aug 2015.